These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 9619537)
21. Ovarian hyperstimulation syndrome: a clinical report on 4894 consecutive ART treatment cycles. Sousa M; Cunha M; Teixeira da Silva J; Oliveira C; Silva J; Viana P; Barros A Reprod Biol Endocrinol; 2015 Jun; 13():66. PubMed ID: 26100393 [TBL] [Abstract][Full Text] [Related]
22. [Jugular vein thrombosis, subclavian vein thrombosis and right brachiocephalic vein thrombosis after in vitro fertilization and embryo transfer: a case report]. Gong F; Cai S; Lu G Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 May; 36(5):453-6. PubMed ID: 21685703 [TBL] [Abstract][Full Text] [Related]
23. Severe early ovarian hyperstimulation syndrome following GnRH agonist trigger with the addition of 1500 IU hCG. Seyhan A; Ata B; Polat M; Son WY; Yarali H; Dahan MH Hum Reprod; 2013 Sep; 28(9):2522-8. PubMed ID: 23633553 [TBL] [Abstract][Full Text] [Related]
24. Course of ovarian hyperstimulation syndrome in 19 intact twin pregnancies after assisted reproduction techniques, with a case report of severe thromboembolism. Cupisti S; Emran J; Mueller A; Dittrich R; Beckmann MW; Binder H Twin Res Hum Genet; 2006 Oct; 9(5):691-6. PubMed ID: 17032552 [TBL] [Abstract][Full Text] [Related]
25. Low dose human chorionic gonadotropin administration at the time of gonadotropin releasing-hormone agonist trigger versus 35 h later in women at high risk of developing ovarian hyperstimulation syndrome - a prospective randomized double-blind clinical trial. Engmann LL; Maslow BS; Kaye LA; Griffin DW; DiLuigi AJ; Schmidt DW; Grow DR; Nulsen JC; Benadiva CA J Ovarian Res; 2019 Jan; 12(1):8. PubMed ID: 30684970 [TBL] [Abstract][Full Text] [Related]
26. Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF/ICSI cycles. Toftager M; Bogstad J; Bryndorf T; Løssl K; Roskær J; Holland T; Prætorius L; Zedeler A; Nilas L; Pinborg A Hum Reprod; 2016 Jun; 31(6):1253-64. PubMed ID: 27060174 [TBL] [Abstract][Full Text] [Related]
27. Update on ovarian hyperstimulation syndrome: part 2--clinical signs and treatment. Binder H; Dittrich R; Einhaust F; Krieg J; Müller A; Strauss R; Beckmann MW; Cupisti S Int J Fertil Womens Med; 2007; 52(2-3):69-81. PubMed ID: 18320864 [TBL] [Abstract][Full Text] [Related]
28. Ventriculoperitoneal shunt failure as a secondary complication of ovarian hyperstimulation syndrome. Case report. Lee GY; Daniel RT; Jones NR J Neurosurg; 2002 Oct; 97(4):992-4. PubMed ID: 12405393 [TBL] [Abstract][Full Text] [Related]
30. Ovarian hyperstimulation presenting as acute hydrothorax after in vitro fertilization. Kingsland CR; Collins JV; Rizk B; Mason BA Am J Obstet Gynecol; 1989 Aug; 161(2):381-2. PubMed ID: 2764057 [TBL] [Abstract][Full Text] [Related]
31. A novel oocyte maturation trigger using 1500 IU of human chorionic gonadotropin plus 450 IU of follicle-stimulating hormone may decrease ovarian hyperstimulation syndrome across all in vitro fertilization stimulation protocols. Anaya Y; Mata DA; Letourneau J; Cakmak H; Cedars MI; Rosen MP J Assist Reprod Genet; 2018 Feb; 35(2):297-307. PubMed ID: 29086322 [TBL] [Abstract][Full Text] [Related]
32. Internal jugular vein thrombosis: a late complication of ovarian hyperstimulation syndrome despite mini-dose heparin prophylaxis. Hignett M; Spence JE; Claman P Hum Reprod; 1995 Dec; 10(12):3121-3. PubMed ID: 8822426 [TBL] [Abstract][Full Text] [Related]
33. [The ovarian hyperstimulation syndrome in pregnancy after IVF-ET]. Kozovski I; Markova V; Andonov M Akush Ginekol (Sofiia); 1998; 37(2):26-7. PubMed ID: 9859531 [TBL] [Abstract][Full Text] [Related]